UK Tests Faster Ethics Review Of Non COVID-19 Trials
Pilot Aims To Deliver Final Ethics Opinion In 15 Days
Executive Summary
The UK’s Health Research Authority is testing whether clinical trial sponsors have an appetite for a new rapid ethics review service covering non COVID-19 research.
You may also be interested in...
Pharma Industry Urges UK To Make Good On Its Clinical Trial Promises
Research-based drug companies are asking for swift implementation of UK clinical trial reforms to ensure the country does not lose out on commercial trial activity amid challenges such as capacity constraints in the NHS and delays in regulatory approvals.
Industry Calls For Urgent Action As UK Drops In Global Ranking For Clinical Trials
The UK’s research-based industry association has issued a dire warning over the UK’s “deteriorating ability to attract and deliver industry clinical trials.”
UK To Use COVID-19 Learnings To Speed Up Review Of Other Trials
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.